Drugs / Horse -Anti-thymocyte
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04370795 Comparator | Nov 2025 | severe combined immunodeficiency | National Institute of Allergy and Infectious Diseases (NIAID) | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Horse -Anti-thymocyte | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04370795 ↗ |
| Known as | h-ATG | “horse anti-thymocyte globulin (h-ATG)” NCT04370795 ↗ |
| Modality | Protein / enzyme biologic | “horse anti-thymocyte globulin (h-ATG)” NCT04370795 ↗ |